Zesiewicz et al. examined 5 studies arising from Europe and USA and reported that the ability of COMT inhibition to reduce or prevent hyperhomocysteinemia induced by levodopa in PD patients may be attributed to differences in the vitamin status of the study participants. This evidence concerns the gene COMT and Parkinson disease.